Clinical Trial Update: Clinical Trial of the Use of Ketamine in Treatment Resistant Depression [Phase 4]

View source ↗

Summary

This entry notes a Phase 4 clinical trial evaluating ketamine for treatment-resistant depression, with the trial status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: National Institute of Neurology and Neurosurgery, Mexico | Conditions: Depressive Disorder, Treatment-Resistant | Phase 4 | Status: UNKNOWN